Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04993677
Title A Study of SEA-CD40 Given With Other Drugs in Cancers
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Seagen Inc.
Indications

lung non-squamous non-small cell carcinoma

uveal melanoma

melanoma

Therapies

Carboplatin + Pembrolizumab + Pemetrexed Disodium + SEA-CD40

Pembrolizumab + SEA-CD40

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.